TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized, multicenter, open-label trial.

John Glaspy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.